Dual Targeting of MDMX and MDM2 Has Antileukemic Activity [Research Watch]

A p53-stapled peptide, ALRN-6924, blocks binding to MDMX and MDM2 to activate p53.

from Cancer via ola Kala on Inoreader https://ift.tt/2qP8GNj
via IFTTT